Gilead Sciences
GILD
#124
Rank
$142.09 B
Marketcap
$114.23
Share price
1.06%
Change (1 day)
46.96%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): $6.82 Billion USD

According to Gilead Sciences's latest financial reports the company's current earnings are $28.73 Billion USD. In 2024 the company made an earning of $0.69 Billion USD a decrease over its 2023 earnings that were of $6.85 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $6.82 B889.13%
2024 $0.69 B-89.94%
2023 $6.85 B17.97%
2022 $5.81 B-29.77%
2021 $8.27 B395.99%
2020 $1.66 B-67.66%
2019 $5.16 B-33.84%
2018 $7.79 B-42.35%
2017 $13.52 B-20.87%
2016 $17.09 B-21.06%
2015 $21.65 B45.8%
2014 $14.85 B253.01%
2013 $4.20 B16.51%
2012 $3.61 B-1.07%
2011 $3.65 B-6.71%
2010 $3.91 B11.75%
2009 $3.50 B29.5%
2008 $2.70 B19.11%
2007 $2.27 B-455.74%
2006 -$0.64 Billion-154.93%
2005 $1.16 B76.99%
2004 $0.65 B-266.16%
2003 -$0.4 Billion-638.24%
2002 $73.39 M31.5%
2001 $55.81 M-242.15%
2000 -$39.27 Million-40.2%
1999 -$65.67 Million31.85%
1998 -$49.8 Million8.73%
1997 -$45.8 Million27.22%
1996 -$36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$6.65 B-2.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
-$0.28 Billion-104.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$3.62 B-46.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-$0.79 Billion-111.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.75 B-74.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$10.34 B 51.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$27.40 B 301.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$13.60 B 99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$21.45 B 214.29%๐Ÿ‡บ๐Ÿ‡ธ USA